Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 5/2016

01-11-2016 | Gynecologic Oncology

The prognostic value and clinicopathological significance of CD44 expression in ovarian cancer: a meta-analysis

Authors: Luyang Zhao, Chenglei Gu, Ke Huang, Zhe Zhang, Mingxia Ye, Wensheng Fan, Weidong Han, Yuanguang Meng

Published in: Archives of Gynecology and Obstetrics | Issue 5/2016

Login to get access

Abstract

Purpose

The prognostic value and clinicopathological significance of CD44 in ovarian cancer (OC) remain unclear. This meta-analysis, therefore, aims to evaluate the correlation between CD44 expression and OC.

Methods

Studies published until March 2016 were searched in PubMed, EMBASE, and ISI Web of Knowledge databases. The odds ratio (OR) and the hazard ratio (HR) with 95 % confidence interval (CI) were used to assess the effects.

Results

Twenty-four studies that include 2267 OC patients were identified for the final analysis. Sixteen studies investigated the expression difference of CD44 standard (CD44s) in 1848 patients. Results showed that high CD44s expression is associated with chemoresistance (OR 5.94, 95 % CI 1.91–18.47) and short disease-free survival (DFS) time (HR 2.57, 95 % CI 1.34–4.91). In addition, CD44s expression is not associated with tumor differentiation grade, residual mass, lymphoid nodal metastasis, and overall survival (OS). Ten studies investigated the expression difference of CD44v6 in 724 patients. Results showed that the CD44v6 expression is not correlated with FIGO stage, tumor differentiation grade, lymphoid nodal metastasis, and OS.

Conclusion

High CD44s expression possibly indicates poor prognosis in OC patients given that high CD44s expression initiates chemotherapy resistance, although this expression pattern is not an independent predictive factor for OS. Meanwhile, high CD44s expression may be related to poor DFS of OC, but this relationship must be further confirmed. In addition, the result in which CD44v6 is not associated with OS of OC patients should be interpreted with caution.
Appendix
Available only for authorised users
Literature
3.
go back to reference Winter WE 3rd, Maxwell GL, Tian C, Carlson JW, Ozols RF, Rose PG, Markman M, Armstrong DK, Muggia F, McGuire WP, Gynecologic Oncology Group S (2007) Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol Off J Am Soc Clin Oncol 25(24):3621–3627. doi:10.1200/JCO.2006.10.2517 CrossRef Winter WE 3rd, Maxwell GL, Tian C, Carlson JW, Ozols RF, Rose PG, Markman M, Armstrong DK, Muggia F, McGuire WP, Gynecologic Oncology Group S (2007) Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol Off J Am Soc Clin Oncol 25(24):3621–3627. doi:10.​1200/​JCO.​2006.​10.​2517 CrossRef
4.
go back to reference Winter WE 3rd, Maxwell GL, Tian C, Sundborg MJ, Rose GS, Rose PG, Rubin SC, Muggia F, McGuire WP, Gynecologic Oncology G (2008) Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol Off J Am Soc Clin Oncol 26(1):83–89. doi:10.1200/JCO.2007.13.1953 CrossRef Winter WE 3rd, Maxwell GL, Tian C, Sundborg MJ, Rose GS, Rose PG, Rubin SC, Muggia F, McGuire WP, Gynecologic Oncology G (2008) Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol Off J Am Soc Clin Oncol 26(1):83–89. doi:10.​1200/​JCO.​2007.​13.​1953 CrossRef
5.
go back to reference Bogush TA, Popova AS, Dudko EA, Bogush EA, Tyulyandina AS, Tyulyandin SA, Davydov MI (2015) ERCC1 as a marker of ovarian cancer resistance to platinum drugs. Antibiot Khimioterapiia Antibiot Chemoterapy [sic]/Minist Med Mikrobiol Prom SSSR 60(3–4):42–50 Bogush TA, Popova AS, Dudko EA, Bogush EA, Tyulyandina AS, Tyulyandin SA, Davydov MI (2015) ERCC1 as a marker of ovarian cancer resistance to platinum drugs. Antibiot Khimioterapiia Antibiot Chemoterapy [sic]/Minist Med Mikrobiol Prom SSSR 60(3–4):42–50
11.
go back to reference Naor D, Sionov RV, Ish-Shalom D (1997) CD44: structure, function, and association with the malignant process. Adv Cancer Res 71:241–319CrossRefPubMed Naor D, Sionov RV, Ish-Shalom D (1997) CD44: structure, function, and association with the malignant process. Adv Cancer Res 71:241–319CrossRefPubMed
12.
go back to reference Volz Y, Koschut D, Matzke-Ogi A, Dietz MS, Karathanasis C, Richert L, Wagner MG, Mely Y, Heilemann M, Niemann HH, Orian-Rousseau V (2015) Direct binding of hepatocyte growth factor and vascular endothelial growth factor to CD44v6. Biosci Rep 35(4):e00236. doi:10.1042/BSR20150093 CrossRefPubMedPubMedCentral Volz Y, Koschut D, Matzke-Ogi A, Dietz MS, Karathanasis C, Richert L, Wagner MG, Mely Y, Heilemann M, Niemann HH, Orian-Rousseau V (2015) Direct binding of hepatocyte growth factor and vascular endothelial growth factor to CD44v6. Biosci Rep 35(4):e00236. doi:10.​1042/​BSR20150093 CrossRefPubMedPubMedCentral
13.
go back to reference Preca BT, Bajdak K, Mock K, Sundararajan V, Pfannstiel J, Maurer J, Wellner U, Hopt UT, Brummer T, Brabletz S, Brabletz T, Stemmler MP (2015) A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells. Int J Cancer J Int Cancer 137(11):2566–2577. doi:10.1002/ijc.29642 CrossRef Preca BT, Bajdak K, Mock K, Sundararajan V, Pfannstiel J, Maurer J, Wellner U, Hopt UT, Brummer T, Brabletz S, Brabletz T, Stemmler MP (2015) A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells. Int J Cancer J Int Cancer 137(11):2566–2577. doi:10.​1002/​ijc.​29642 CrossRef
14.
go back to reference Wu Y, Li Z, Zhang C, Yu K, Teng Z, Zheng G, Wang S, Liu Y, Cui L, Yu X (2015) CD44 family proteins in gastric cancer: a meta-analysis and narrative review. Int J Clin Exp Med 8(3):3595–3606PubMedPubMedCentral Wu Y, Li Z, Zhang C, Yu K, Teng Z, Zheng G, Wang S, Liu Y, Cui L, Yu X (2015) CD44 family proteins in gastric cancer: a meta-analysis and narrative review. Int J Clin Exp Med 8(3):3595–3606PubMedPubMedCentral
19.
go back to reference Yorishima T, Nagai N, Ohama K (1997) Expression of CD44 alternative splicing variants in primary and lymph node metastatic lesions of gynecological cancer. Hiroshima J Med Sci 46(1):21–29PubMed Yorishima T, Nagai N, Ohama K (1997) Expression of CD44 alternative splicing variants in primary and lymph node metastatic lesions of gynecological cancer. Hiroshima J Med Sci 46(1):21–29PubMed
20.
go back to reference Darai E, Walker-Combrouze F, Fauconnier A, Madelenat P, Potet F, Scoazec JY (1998) Analysis of CD44 expression in serous and mucinous borderline tumours of the ovary: comparison with cystadenomas and overt carcinomas. Histopathology 32(2):151–159CrossRefPubMed Darai E, Walker-Combrouze F, Fauconnier A, Madelenat P, Potet F, Scoazec JY (1998) Analysis of CD44 expression in serous and mucinous borderline tumours of the ovary: comparison with cystadenomas and overt carcinomas. Histopathology 32(2):151–159CrossRefPubMed
21.
go back to reference Kayastha S, Freedman AN, Piver MS, Mukkamalla J, Romero-Guittierez M, Werness BA (1999) Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survival. Clin Cancer Res Off J Am Assoc Cancer Res 5(5):1073–1076 Kayastha S, Freedman AN, Piver MS, Mukkamalla J, Romero-Guittierez M, Werness BA (1999) Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survival. Clin Cancer Res Off J Am Assoc Cancer Res 5(5):1073–1076
23.
go back to reference Schroder W, Rudlowski C, Biesterfeld S, Knobloch C, Hauptmann S, Rath W (1999) Expression of CD44(v5-10) splicing variants in primary ovarian cancer and lymph node metastases. Anticancer Res 19(5B):3901–3906PubMed Schroder W, Rudlowski C, Biesterfeld S, Knobloch C, Hauptmann S, Rath W (1999) Expression of CD44(v5-10) splicing variants in primary ovarian cancer and lymph node metastases. Anticancer Res 19(5B):3901–3906PubMed
24.
go back to reference Afify AM, Ferguson AW, Davila RM, Werness BA (2001) Expression of CD44S and CD44v5 is more common in stage III than in stage I serous ovarian carcinomas. Appl Immunohistochem Mol Morphol AIMM/Off Publ Soc Appl Immunohistochem 9(4):309–314CrossRef Afify AM, Ferguson AW, Davila RM, Werness BA (2001) Expression of CD44S and CD44v5 is more common in stage III than in stage I serous ovarian carcinomas. Appl Immunohistochem Mol Morphol AIMM/Off Publ Soc Appl Immunohistochem 9(4):309–314CrossRef
25.
go back to reference Ross JS, Sheehan CE, Williams SS, Malfetano JH, Szyfelbein WM, Kallakury BV (2001) Decreased CD44 standard form expression correlates with prognostic variables in ovarian carcinomas. Am J Clin Pathol 116(1):122–128. doi:10.1309/KUK0-1M3D-LGNE-THXR CrossRefPubMed Ross JS, Sheehan CE, Williams SS, Malfetano JH, Szyfelbein WM, Kallakury BV (2001) Decreased CD44 standard form expression correlates with prognostic variables in ovarian carcinomas. Am J Clin Pathol 116(1):122–128. doi:10.​1309/​KUK0-1M3D-LGNE-THXR CrossRefPubMed
26.
27.
go back to reference Sillanpaa S, Anttila MA, Voutilainen K, Tammi RH, Tammi MI, Saarikoski SV, Kosma VM (2003) CD44 expression indicates favorable prognosis in epithelial ovarian cancer. Clinical Cancer Res Off J Am Assoc Cancer Res 9(14):5318–5324 Sillanpaa S, Anttila MA, Voutilainen K, Tammi RH, Tammi MI, Saarikoski SV, Kosma VM (2003) CD44 expression indicates favorable prognosis in epithelial ovarian cancer. Clinical Cancer Res Off J Am Assoc Cancer Res 9(14):5318–5324
28.
go back to reference Qu JY, Li S, Lin H, Wu JB, Wang YQ (2004) Relationship between expression of hyaluronan and pathologic features of ovarian adenocarcinoma. Ai zheng Aizheng Chin J Cancer 23(2):177–180 Qu JY, Li S, Lin H, Wu JB, Wang YQ (2004) Relationship between expression of hyaluronan and pathologic features of ovarian adenocarcinoma. Ai zheng Aizheng Chin J Cancer 23(2):177–180
29.
go back to reference Zagorianakou N, Stefanou D, Makrydimas G, Zagorianakou P, Briasoulis E, Karavasilis B, Agnantis NJ (2004) CD44s expression, in benign, borderline and malignant tumors of ovarian surface epithelium. Correlation with p53, steroid receptor status, proliferative indices (PCNA, MIB1) and survival. Anticancer Res 24(3a):1665–1670PubMed Zagorianakou N, Stefanou D, Makrydimas G, Zagorianakou P, Briasoulis E, Karavasilis B, Agnantis NJ (2004) CD44s expression, in benign, borderline and malignant tumors of ovarian surface epithelium. Correlation with p53, steroid receptor status, proliferative indices (PCNA, MIB1) and survival. Anticancer Res 24(3a):1665–1670PubMed
31.
go back to reference Steffensen KD, Alvero AB, Yang Y, Waldstrom M, Hui P, Holmberg JC, Silasi DA, Jakobsen A, Rutherford T, Mor G (2011) Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer. J Oncol 2011:620523. doi:10.1155/2011/620523 CrossRefPubMedPubMedCentral Steffensen KD, Alvero AB, Yang Y, Waldstrom M, Hui P, Holmberg JC, Silasi DA, Jakobsen A, Rutherford T, Mor G (2011) Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer. J Oncol 2011:620523. doi:10.​1155/​2011/​620523 CrossRefPubMedPubMedCentral
35.
go back to reference Ryabtseva OD, Lukianova NY, Shmurakov YA, Polishchuk LZ, Antipova SV (2013) Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis. Exp Oncol 35(3):211–218PubMed Ryabtseva OD, Lukianova NY, Shmurakov YA, Polishchuk LZ, Antipova SV (2013) Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis. Exp Oncol 35(3):211–218PubMed
37.
go back to reference Wang A, Lu L, Wang Y, Sun Y, Zhang Y, Guo C, Gu Y, Liu A (2014) Expression and clinicopathologic significance of CD44v6/CD24 in ovarian serous carcinomas. Zhonghua bing li xue za zhi Chin J Pathol 43(1):20–24 Wang A, Lu L, Wang Y, Sun Y, Zhang Y, Guo C, Gu Y, Liu A (2014) Expression and clinicopathologic significance of CD44v6/CD24 in ovarian serous carcinomas. Zhonghua bing li xue za zhi Chin J Pathol 43(1):20–24
39.
go back to reference Tjhay F, Motohara T, Tayama S, Narantuya D, Fujimoto K, Guo J, Sakaguchi I, Honda R, Tashiro H, Katabuchi H (2015) CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer. Cancer Sci 106(10):1421–1428. doi:10.1111/cas.12765 CrossRefPubMedPubMedCentral Tjhay F, Motohara T, Tayama S, Narantuya D, Fujimoto K, Guo J, Sakaguchi I, Honda R, Tashiro H, Katabuchi H (2015) CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer. Cancer Sci 106(10):1421–1428. doi:10.​1111/​cas.​12765 CrossRefPubMedPubMedCentral
40.
go back to reference Zhu LC, Gao J, Hu ZH, Schwab CL, Zhuang HY, Tan MZ, Yan LM, Liu JJ, Zhang DY, Lin B (2015) Membranous expressions of Lewis y and CAM-DR-related markers are independent factors of chemotherapy resistance and poor prognosis in epithelial ovarian cancer. Am J Cancer Res 5(2):830–843PubMedPubMedCentral Zhu LC, Gao J, Hu ZH, Schwab CL, Zhuang HY, Tan MZ, Yan LM, Liu JJ, Zhang DY, Lin B (2015) Membranous expressions of Lewis y and CAM-DR-related markers are independent factors of chemotherapy resistance and poor prognosis in epithelial ovarian cancer. Am J Cancer Res 5(2):830–843PubMedPubMedCentral
42.
go back to reference Elzarkaa AA, Sabaa BE, Abdelkhalik D, Mansour H, Melis M, Shaalan W, Farouk M, Malik E, Soliman AA (2016) Clinical relevance of CD44 surface expression in advanced stage serous epithelial ovarian cancer: a prospective study. J Cancer Res Clin Oncol. doi:10.1007/s00432-016-2116-5 PubMed Elzarkaa AA, Sabaa BE, Abdelkhalik D, Mansour H, Melis M, Shaalan W, Farouk M, Malik E, Soliman AA (2016) Clinical relevance of CD44 surface expression in advanced stage serous epithelial ovarian cancer: a prospective study. J Cancer Res Clin Oncol. doi:10.​1007/​s00432-016-2116-5 PubMed
43.
go back to reference Nagano O, Saya H (2004) Mechanism and biological significance of CD44 cleavage. Cancer Sci 95(12):930–935CrossRefPubMed Nagano O, Saya H (2004) Mechanism and biological significance of CD44 cleavage. Cancer Sci 95(12):930–935CrossRefPubMed
45.
go back to reference Lundell BI, McCarthy JB, Kovach NL, Verfaillie CM (1997) Activation of beta1 integrins on CML progenitors reveals cooperation between beta1 integrins and CD44 in the regulation of adhesion and proliferation. Leukemia 11(6):822–829CrossRefPubMed Lundell BI, McCarthy JB, Kovach NL, Verfaillie CM (1997) Activation of beta1 integrins on CML progenitors reveals cooperation between beta1 integrins and CD44 in the regulation of adhesion and proliferation. Leukemia 11(6):822–829CrossRefPubMed
48.
go back to reference Mashayekhi F, Aryaee H, Mirzajani E, Yasin AA, Fathi A (2015) Soluble CD44 concentration in the serum and peritoneal fluid samples of patients with different stages of endometriosis. Arch Gynecol Obstet 292(3):641–645. doi:10.1007/s00404-015-3654-9 CrossRefPubMed Mashayekhi F, Aryaee H, Mirzajani E, Yasin AA, Fathi A (2015) Soluble CD44 concentration in the serum and peritoneal fluid samples of patients with different stages of endometriosis. Arch Gynecol Obstet 292(3):641–645. doi:10.​1007/​s00404-015-3654-9 CrossRefPubMed
49.
go back to reference Xu H, Tian Y, Yuan X, Liu Y, Wu H, Liu Q, Wu GS, Wu K (2016) Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis. OncoTargets Ther 9:431–444. doi:10.2147/OTT.S97192 Xu H, Tian Y, Yuan X, Liu Y, Wu H, Liu Q, Wu GS, Wu K (2016) Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis. OncoTargets Ther 9:431–444. doi:10.​2147/​OTT.​S97192
51.
go back to reference Morrison R, Schleicher SM, Sun Y, Niermann KJ, Kim S, Spratt DE, Chung CH, Lu B (2011) Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis. J Oncol 2011:941876. doi:10.1155/2011/941876 CrossRefPubMed Morrison R, Schleicher SM, Sun Y, Niermann KJ, Kim S, Spratt DE, Chung CH, Lu B (2011) Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis. J Oncol 2011:941876. doi:10.​1155/​2011/​941876 CrossRefPubMed
Metadata
Title
The prognostic value and clinicopathological significance of CD44 expression in ovarian cancer: a meta-analysis
Authors
Luyang Zhao
Chenglei Gu
Ke Huang
Zhe Zhang
Mingxia Ye
Wensheng Fan
Weidong Han
Yuanguang Meng
Publication date
01-11-2016
Publisher
Springer Berlin Heidelberg
Published in
Archives of Gynecology and Obstetrics / Issue 5/2016
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-016-4137-3

Other articles of this Issue 5/2016

Archives of Gynecology and Obstetrics 5/2016 Go to the issue